Lingyun Lai

机构：Fudan University, Huashan Hospital · ORCID：0000-0002-0603-8750

发表论文 39 篇 · 总被引 1291 次 · h-index 15

代表论文

• Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy (2022 · JAMA · 被引 343)
• Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial (2023 · The Lancet · 被引 198)
• miR-15b induces premature ovarian failure in mice via inhibition of α-Klotho expression in ovarian granulosa cells (2019 · Free Radical Biology and Medicine · 被引 80)
• Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 study (2025 · The Lancet · 被引 42)
• An inhibitor with GSK3β and DYRK1A dual inhibitory properties reduces Tau hyperphosphorylation and ameliorates disease in models of Alzheimer's disease (2023 · Neuropharmacology · 被引 29)
• Ranitidine and finasteride inhibit the synthesis and release of trimethylamine N-oxide and mitigates its cardiovascular and renal damage through modulating gut microbiota (2020 · International Journal of Biological Sciences · 被引 27)